5 pending office actions • 4 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (20%) |
| §101 + other | 1 (20%) |
| §103 only | 2 (40%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAILEY, STEVEN WILLIAM | 2 | 32.0% | +20.2% |
| MONTGOMERY, ANN Y | 1 | 69.4% | +27.1% |
| SCHACHERMEYER, SAMANTHA LYNN | 1 | 36.1% | +70.8% |
| MEYERING, SHABANA SHABBEER | 1 | 69.7% | +41.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17514269 | High-Capacity Storage of Digital Information in DNA | BAILEY, STEVEN WILLIAM | 59d overdue |
| 16460051 | High-Capacity Storage of Digital Information in DNA | BAILEY, STEVEN WILLIAM | 19d |
| 17426338 | MEANS AND METHODS FOR PREPARING ENGINEERED TARGET PROTEINS BY GENETIC CODE EXPANSION IN A TARGET PROTEIN-SELECTIVE MANNER | MEYERING, SHABANA SHABBEER | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17514269 | High-Capacity Storage of Digital Information in DNA | BAILEY, STEVEN WILLIAM | 59d overdue |
| 16460051 | High-Capacity Storage of Digital Information in DNA | BAILEY, STEVEN WILLIAM | 19d |
| 18556778 | QUANTIFICATION OF SUCCESSFUL ENCAPSULATION INTO MICROFLUIDIC COMPARTMENTS | MONTGOMERY, ANN Y | — |
| 17782654 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND/OR TREATMENT OF DYSBIOSIS AND ANTIBACTERIAL ANTIDOTES FOR MICROBIOME-PROTECTION | SCHACHERMEYER, SAMANTHA LYNN | — |
| 17426338 | MEANS AND METHODS FOR PREPARING ENGINEERED TARGET PROTEINS BY GENETIC CODE EXPANSION IN A TARGET PROTEIN-SELECTIVE MANNER | MEYERING, SHABANA SHABBEER | — |
| Art Unit | Apps |
|---|---|
| 1687 | 2 |
| 1678 | 1 |
| 1693 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18556778 | QUANTIFICATION OF SUCCESSFUL ENCAPSULATION INTO MICROFLUIDIC COMPARTMENTS | MONTGOMERY, ANN Y | 1678 | §103 | Non-Final OA | — | Pending | Oct 23, 2023 |
| 17782654 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND/OR TREATMENT OF DYSBIOSIS AND ANTIBACTERIAL ANTIDOTES FOR MICROBIOME-PROTECTION | SCHACHERMEYER, SAMANTHA LYNN | 1693 | §103 | Final Rejection | — | Pending | Jun 05, 2022 |
| 17514269 | High-Capacity Storage of Digital Information in DNA | BAILEY, STEVEN WILLIAM | 1687 | §101Other | Final Rejection | 59d overdue | Pending | Oct 29, 2021 |
| 17426338 | MEANS AND METHODS FOR PREPARING ENGINEERED TARGET PROTEINS BY GENETIC CODE EXPANSION IN A TARGET PROTEIN-SELECTIVE MANNER | MEYERING, SHABANA SHABBEER | 1635 | §102§103§112 | Non-Final OA | — | Pending | Jul 28, 2021 |
| 16460051 | High-Capacity Storage of Digital Information in DNA | BAILEY, STEVEN WILLIAM | 1687 | §101§102 | Final Rejection | 19d | Pending | Jul 02, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial